Best Momentum Stocks to Buy for July 3rd [Yahoo! Finance]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Yahoo! Finance
Sarepta Therapeutics, Inc. SRPT: This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 61.3% over the last 60 days. Sarepta's shares gained 22.6% over the last three months compared with the S&P 500's advance of 7%. The company possesses a Momentum Score of A. Amtech Systems, Inc. ASYS: This manufacturer of essential equipment and consumables used in the semiconductor and automotive industries has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 70.6% over the last 60 days. Amtech's shares gained 15.6% over the last three months compared with the S&P 500's advance of 7%. The company possesses a Momentum Score of B. See the full list of top ranked stocks here Learn more about the Momentum score and how it is calculated here Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- After a Big Win, Is Sarepta Therapeutics Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News? [Yahoo! Finance]Yahoo! Finance
- 1 Soaring Growth Stock to Buy and Hold for 10 Years [Yahoo! Finance]Yahoo! Finance
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $205.00 price target on the stock.MarketBeat
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
SRPT
Earnings
- 5/1/24 - Beat
SRPT
Sec Filings
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- SRPT's page on the SEC website